Hims & Hers Health

Hims & Hers Health

Prezzo: 26.82

Società e modello di business

Hims & Hers Health is a healthcare company that provides telehealth services and wellness products, focusing on personal health and wellness solutions. Its core offerings include prescription medications, over-the-counter products, and health consultations, primarily targeting issues such as sexual health, hair loss, and skincare. The company operates through direct-to-consumer channels, generating revenue from subscription services and product sales.

Profilo di investimento

The investment profile of Hims & Hers Health is more aligned with growth investors, given its focus on expanding its service offerings and market reach. The company currently does not provide dividends and has shown volatility in its earnings. Investors should consider the potential for future growth against the backdrop of higher risk factors.

Sito ufficiale

Metriche fondamentali (sperimentale)

EPS (TTM) — utile per azione degli ultimi 12 mesi, $
-0.05 Rischio
Ricavi QoQ — crescita dei ricavi trimestre su trimestre
-1.6%
Sorpresa EPS
-550.0% peggio del previsto
Volatilità 20g
4.6% stabile
Dati FMP / FinFeed aggiornati: 2026-06-13

Impatto della previsione

neutrale
Target abbassato · UBS · valido fino a 2026-06-25 · aggiornato 2026-06-13
Target -6.8% raggiungimento target 107.3%
Reazione D5 -15.83% · D10 -12.01%
Impatto Potenziale 0 · Rischio 0 fino a 30 giorni o finché il target non viene raggiunto
Racc.: Vendi Potenziale: 31 Rischio: 70 Aggiornato: 2026-06-13 02:40
Come funziona la raccomandazione
Perché l'AI la pensa così:
Weak fundamentals and negative momentum raise significant concerns.

Traccia in portafoglio

Grafico prezzo

Raccomandazione AI Previsione analista Evento calendario Segnale positivo Segnale negativo Neutrale / aggiornamento Mantieni / informativo B My buy S My sell
Cambiamenti di raccomandazione AI
Data Prima Dopo Motivo
2026-05-30 02:41 Mantieni Vendi Weak fundamentals and high volatility raise significant concerns.
2026-05-14 03:36 Compra Mantieni Weak momentum and high risk; uncertain growth outlook.
2026-05-10 02:33 Mantieni Compra Strong momentum and positive EPS surprise indicate growth potential.
Previsioni analisti
Data Analista Action Target Prezzo allora
2026-06-02 12:19 Leerink Partners Aggiorna — → 25 27.635
2026-05-26 09:25 UBS Target abbassato — → 25 23.75
2026-05-22 14:00 UBS Target alzato 18 → 23 23.88

Ancora nulla